Clinical Trial

The Impact of Fexofenadine Hydrochloride on the Prognosis of Patients Post-Acute Myocardial Infarction

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The goal of this study is o evaluate the prognostic effect of fexofenadine hydrochloride in patients with myocardial infarction
Protocol Amendment History 1 change
notable Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University -> Second Affiliated Hospital, Zhejiang University, School of Medicine 2026-08-08
Trial Details
NCT Number NCT07381803
Lead Sponsor Second Affiliated Hospital, Zhejiang University, School of Medicine
Conditions Zhejiang University
Enrollment 2,804 participants
Start Date 2025-01-27
Primary Completion 2026-12 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-08-07